1 RESEARCH METHODOLOGY, ASSUMPTIONS AND ACRONYMS
2 EXECUTIVE SUMMARY
2.1 GLOBAL DRUG DELIVERY MARKET
3 GLOBAL DRUG DELIVERY MARKET-MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 GLOBAL DRUG DELIVERY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
3.1.2 GLOBAL DRUG DELIVERY MARKET SNAPSHOT
4 GLOBAL DRUG DELIVERY MARKET OVERVIEW- BY DELIVERY ROUTE
4.1 INTRODUCTION
4.1.1 GLOBAL DRUG DELIVERY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY  DELIVERY ROUTE
4.1.1.1 ORAL ROUTE
4.1.1.2 PARENTERAL ROUTE
4.1.1.3 TRANSDERMAL ROUTE
4.1.1.4 INHALATION ROUTE
5 GLOBAL DRUG DELIVERY MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPE
5.1 INTRODUCTION
5.1.1 GLOBAL DRUG DELIVERY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY PRODUCT TYPE
5.1.1.1 AMBULATORY INFUSION PUMPS
5.1.1.2 VALVES
5.1.1.3 NEEDLES
5.1.1.4 PAEDIATRIC IV SET
5.1.1.5 OTHERS

6 GLOBAL DRUG DELIVERY MARKET ANALYSIS AND FORECAST, BY END- USER
6.1 INTRODUCTION
6.1.1 GLOBAL DRUG DELIVERY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET- BY END- USER
6.1.1.1 DIAGNOSTIC CENTERS
6.1.1.2 HOSPITALS
6.1.1.3 AMBULATORY SURGICAL CENTERS
6.1.1.4 OTHERS
7 GLOBAL DRUG DELIVERY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET, BY REGION
7.1 INTRODUCTION
7.2 KEY TAKEWAYS
8 NORTH AMERICA DRUG DELIVERY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
8.1 MARKET DYNAMICS
8.1.1 DRIVERS
8.1.2 RESTRAINTS
8.1.3 OPPORTUNITIES
8.2 NORTH AMERICA DRUG DELIVERY MARKET ANALYSIS- BY DELIVERY ROUTE
8.3 NORTH AMERICA DRUG DELIVERY MARKET ANALYSIS- BY PRODUCT TYPE
8.4 NORTH AMERICA DRUG DELIVERY MARKET ANALYSIS- BY END- USER
8.5 U.S.
8.6 CANADA
8.7 MEXICO
9 EUROPE DRUG DELIVERY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
9.1 MARKET DYNAMICS
9.1.1 DRIVERS
9.1.2 RESTRAINTS
9.1.3 OPPORTUNITIES
9.2 EUROPE DRUG DELIVERY MARKET ANALYSIS- BY DELIVERY ROUTE
9.3 EUROPE DRUG DELIVERY MARKET ANALYSIS- BY PRODUCT TYPE
9.4 EUROPE DRUG DELIVERY MARKET ANALYSIS- BY END- USER
9.5 U.K.
9.6 FRANCE
9.7 GERMANY
9.8 ITALY
9.9 SPAIN
9.10 REST OF EUROPE
10 ASIA PACIFIC DRUG DELIVERY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
10.1 MARKET DYNAMICS
10.1.1 DRIVERS
10.1.2 RESTRAINTS
10.1.3 OPPORTUNITIES
10.2 ASIA PACIFIC DRUG DELIVERY MARKET ANALYSIS- BY DELIVERY ROUTE
10.3 ASIA PACIFIC DRUG DELIVERY MARKET ANALYSIS- BY PRODUCT TYPE
10.4 ASIA PACIFIC DRUG DELIVERY MARKET ANALYSIS- BY END- USER
10.5 INDIA
10.6 CHINA
10.7 JAPAN
10.8 REST OF ASIA PACIFIC
11 MIDDLE EAST AND AFRICA (MEA) DRUG DELIVERY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
11.1 MARKET DYNAMICS
11.1.1 DRIVERS
11.1.2 RESTRAINTS
11.1.3 OPPORTUNITIES
11.2 MEA DRUG DELIVERY MARKET ANALYSIS- BY DELIVERY ROUTE
11.3 MEA DRUG DELIVERY MARKET ANALYSIS- BY PRODUCT TYPE
11.4 MEA DRUG DELIVERY MARKET ANALYSIS- BY END- USER
11.5 SOUTH AFRICA
11.6 REST OF MIDDLE EAST AND AFRICA
12 LATIN AMERICA DRUG DELIVERY MARKET REVENUE FORECAST AND POTENTIAL ADDRESSABLE MARKET
12.1 MARKET DYNAMICS
12.1.1 DRIVERS
12.1.2 RESTRAINTS
12.1.3 OPPORTUNITIES
12.2 LATIN AMERICA DRUG DELIVERY MARKET ANALYSIS- BY DELIVERY ROUTE
12.3 LATIN AMERICA DRUG DELIVERY MARKET ANALYSIS- BY PRODUCT TYPE
12.4 LATIN AMERICA DRUG DELIVERY MARKET ANALYSIS- BY END- USER
12.5 BRAZIL
12.6 REST OF LATIN AMERICA
13 COMPETATIVE LANDSCAPE
13.1 GLOBAL DRUG DELIVERY MARKET-COMPANY MARKET SHARE ANALYSIS
14 COMPANY PROFILES: (REVENUE,  DELIVERY ROUTES/BRAND OFFERINGS, COMPANY HIGHLIGHTS)
14.1 ANTARES PHARMA, INC.
14.2 BECTON, DICKINSON AND COMPANY
14.3 BAYER AG
14.4 BOSTON SCIENTIFIC CORPORATION
14.5 GLAXSMITHKLINE PLC
14.6 JOHNSON & JOHNSON SERVICES, INC.
14.7 MERCK & CO.,INC.
14.8 NOVARTIS AG
14.9 PFIZER, INC.
14.10 SANOFI